The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| EMGE | -62.5% | -99.67% | -67.82% | -100% |
| S&P | +13.95% | +78.35% | +12.25% | +369% |
No news articles found for Emergent Health.
| Q3 2024 | YOY Change | |
|---|---|---|
| Revenue | $0.00K | 0.0% |
| Gross Profit | $0.00K | 0.0% |
| Gross Margin | 62.88% | 0.0% |
| Market Cap | $56.60K | 0.0% |
| Net Income | -$64.55K | 0.0% |
| EBITDA | -$2.78K | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2024 | YOY Change | |
|---|---|---|
| Net Cash | $0.23K | 0.0% |
| Inventory | 0 | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00K | 0.0% |
| Short Term Debt | $2.66M | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Return On Assets | -167.61% | 0.0% |
| Return On Invested Capital | 256.74% | 0.0% |
| Q3 2024 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$56.47K | 0.0% |
| Operating Free Cash Flow | -$56.47K | 0.0% |
| Metric | Q1 2024 | Q2 2024 | Q3 2024 | YoY Change |
|---|---|---|---|---|
| Price to Book | -0.28 | -0.31 | -0.18 | - |
| Price to Sales | 0.39 | 1.17 | 1.72 | - |
| Price to Tangible Book Value | -0.27 | -0.30 | -0.18 | - |
| Enterprise Value to EBITDA | -9.62 | 24.23 | -1203.12 | - |
| Total Debt | $2.92M | $2.60M | $2.66M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
